Evidence map›Paper›PMID 35290357›Full record

ArticleOptics letters2022

3D k-space reflectance fluorescence tomography via deep learning.

Navid Ibtehaj Nizam, Marien Ochoa, Jason T Smith, Xavier Intes

Open access · greenAbstract read
In one paragraph

Article in Optics letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Navid Ibtehaj Nizam
Marien Ochoa
Jason T Smith
Xavier Intes
Rensselaer Polytechnic Institute · US

Funding

Role of tumor heterogeneity on receptor engagementR01CA207725 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI BARROSO, MARGARIDA, CORR, DAVID THOMAS · 2017 to 2021
$3.0M
In vivo Macroscopic Fluorescence Lifetime Molecular Optical ImagingR01CA250636 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI BARROSO, MARGARIDA, INTES, XAVIER · 2020 to 2023
$2.9M
Photon-counting X-ray and Optical Tomography for Preclinical Cancer ResearchR01CA237267 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI BARROSO, MARGARIDA, INTES, XAVIER · 2019 to 2023
$2.9M
NCI NIH HHS R01 CA207725NCI NIH HHS R01 CA237267NCI NIH HHS R01 CA250636
6 · The paper itself

Abstract

We report on the potential to perform image reconstruction in 3D k-space reflectance fluorescence tomography (FT) using deep learning (DL). Herein, we adopt a modified AUTOMAP architecture and develop a training methodology that leverages an open-source Monte-Carlo-based simulator to generate a large dataset. Using an enhanced EMNIST (EEMNIST) dataset as an embedded contrast function allows us to train the network efficiently. The optical strategy utilizes k-space illumination in a reflectance configuration to probe tissue in the mesoscopic regime with high sensitivity and resolution. The proposed DL model training and validation is performed with both in silico data and a phantom experiment. Overall, our results indicate that the approach can correctly reconstruct both single and multiple fluorescent embedding(s) in a 3D volume. Furthermore, the presented technique is shown to outperform the traditional approaches [least-squares (LSQ) and total-variation minimization (TVAL)], especially at higher depths. We, therefore, expect the proposed computational technique to have future implications in preclinical studies.

Indexed as

Deep LearningImage Processing, Computer-AssistedMonte Carlo MethodPhantoms, ImagingTomography

Identifiers

PMID35290357
PMCPMC9335514
OpenAlexW4213220310

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.